文献速递眼底病与葡萄膜炎

厚脉络膜新生血管病变与新生血管性年龄相关性黄斑变性眼内血管内皮生长因子水平比较

Intraocular Vascular Endothelial Growth Factor Levels in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

研究纳入9眼初治厚脉络膜新生血管病变和21眼初治新生血管性年龄相关性黄斑变性(nAMD),比较房水VEGF浓度及其与每月三次抗VEGF注射初始治疗反应的关系。厚脉络膜新生血管病变组平均VEGF浓度显著低于nAMD组(63.4 ± 17.8 pg/ml vs 89.8 ± 45.0 pg/ml,P = 0.035)。厚脉络膜新生血管病变组3个月和12个月黄斑干燥与低VEGF浓度显著相关,nAMD组无此关联。

要点

  • 厚脉络膜新生血管病变房水VEGF均值63.4 ± 17.8 pg/ml,低于nAMD的89.8 ± 45.0 pg/ml(P = 0.035)。
  • VEGF浓度与玻璃膜疣存在与否相关(β = 0.503,P = 0.004)。
  • 抗VEGF治疗后黄斑干燥比例:厚脉络膜新生血管病变6/9眼(66.7%)vs nAMD 17/21眼(81.0%),P = 0.640。

核心结论

  • 厚脉络膜新生血管病变平均VEGF浓度低于nAMD,提示VEGF参与血管新生的方式在两种病变间可能不同。

研究设计与样本

  • 研究纳入9眼初治厚脉络膜新生血管病变和21眼初治nAMD,初始玻璃体内抗VEGF注射前采集房水,用酶联免疫吸附试验测定VEGF浓度。

主要发现

  • 厚脉络膜新生血管病变平均VEGF浓度为63.4 ± 17.8 pg/ml,nAMD为89.8 ± 45.0 pg/ml,组间差异显著(P = 0.035)。
  • VEGF浓度与玻璃膜疣存在与否相关(β = 0.503,P = 0.004)。
  • 抗VEGF治疗后黄斑干燥:厚脉络膜新生血管病变6/9眼(66.7%)vs nAMD 17/21眼(81.0%),P = 0.640。
  • 厚脉络膜新生血管病变组3个月和12个月黄斑干燥与低VEGF浓度显著相关(P = 0.013和P = 0.042),nAMD组无显著关联(P = 0.108和P = 0.219)。

关键数值与推荐

  • 厚脉络膜新生血管病变平均VEGF浓度63.4 ± 17.8 pg/ml,nAMD 89.8 ± 45.0 pg/ml(P = 0.035)。
  • VEGF浓度与玻璃膜疣存在与否的关联:β = 0.503,P = 0.004。
  • 抗VEGF治疗后黄斑干燥:厚脉络膜新生血管病变6/9眼(66.7%)vs nAMD 17/21眼(81.0%),P = 0.640。
  • 厚脉络膜新生血管病变组3个月黄斑干燥与低VEGF浓度相关P = 0.013,12个月P = 0.042;nAMD组分别为P = 0.108和P = 0.219。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the difference in intraocular vascular endothelial growth factor (VEGF) concentration between pachychoroid neovasculopathy and neovascular age-related macular degeneration (nAMD) and its associations with responses to three monthly anti-VEGF injections as an initial treatment for the two conditions. METHODS: This study included nine eyes with treatment-naïve pachychoroid neovasculopathy and 21 eyes with treatment-naïve nAMD. Before the initial intravitreal anti-VEGF injection, aqueous humor samples were collected and the concentration of VEGF was measured using enzyme-linked immunosorbent assay. The concentration was compared between the two conditions, and its associations with responses to anti-VEGF therapy were investigated. RESULTS: The mean VEGF concentration in pachychoroid neovasculopathy was significantly lower than that in nAMD (63.4 ± 17.8 pg/ml and 89.8 ± 45.0 pg/ml, respectively; P = 0.035). The VEGF concentration was associated with the presence or absence of drusen (β = 0.503, P = 0.004). After anti-VEGF therapy, 6 (66.7%) of 9 eyes with pachychoroid neovasculopathy and 17 (81.0%) of 21 eyes with nAMD achieved dry macula (P = 0.640). Dry macula at 3 months and 12 months was significantly associated with a low VEGF concentration in pachychoroid neovasculopathy (P = 0.013 and P = 0.042, respectively), but not in nAMD (P = 0.108 and P = 0.219). CONCLUSIONS: The mean VEGF concentration in pachychoroid neovasculopathy was lower than that in nAMD, suggesting that the way in which VEGF is involved in angiogenesis may differ between pachychoroid neovasculopathy and nAMD.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Hata M, Yamashiro K, Ooto S, et al. Intraocular Vascular Endothelial Growth Factor Levels in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2017. PMID: 28114590. doi:10.1167/iovs.16-20967

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。